Clinical Trials in China / NCT05965375
Starting soon
Observational
Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias
NCT05965375 · tracked via the Priya Life Science China tracker
Condition(s) studied
Ventricular Arrythmia
Investigational drug(s) / intervention(s)
Observational; No Interventions were given.
Observational; No Interventions were given.: Observational; No Interventions were given.
Study summary
The investigation of biomarkers for immune status and metabolic state, as well as host microbiota composition, in patients with ventricular arrhythmias before and after radiofrequency ablation, can provide new insights for specific and personalized treatment. This can help establish early prediction and prognosis models and provide a basis for clinically effective diagnosis and treatment.
Eligibility
Inclusion Criteria:
* Patients with ventricular premature beats, ventricular tachycardia, or ventricular fibrillation detected by regular surface twelve-lead electrocardiogram or Holter.
Exclusion Criteria:
* Age \<18 or \>80 years old;
* Patients with autoimmune diseases or immune deficiencies, or those who have used immunosuppressive or immune modulating agents in the past 3 months;
* Platelet count \<100×10\^9/L or functional platelet defects;
* Congenital or acquired coagulation or bleeding disorders;
* Patients with a history of organ transplantation or are preparing to receive organ transplantation;
* Unwilling to sign an informed consent or cooperate with the examination.
Primary outcome measure(s)
- Change in the incidence of MACCE — 3,6 months,1,3,5 years after enrollment.
Major adverse cardiovascular and cerebrovascular events, including myocardial infarction, stroke, vessel revascularization and all-cause death. The MACCE will be assessed from the medical records.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| First Affiliated Hospital of Xian Jiantong University | Xi'an | Shaanxi |
More First Affiliated Hospital Xi'an Jiaotong University trials in China
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05965375 on ClinicalTrials.gov ↗ ← All trials in China